Literature DB >> 26864469

Can venous ProBNP levels predict placenta accreta?

Ali Ozgur Ersoy1, Efser Oztas1, Sibel Ozler1, Ebru Ersoy1, Kudret Erkenekli1, Dilek Uygur1, Ali Turhan Caglar1, Nuri Danisman1.   

Abstract

AIM: Placenta previa (PP) is a potential life-threatening pregnancy complication. Pro-brain natriuretic peptide (ProBNP), creatine kinase (CK), cardiac form of CK (CK-MB) and Troponin I are circulatory biomarkers related to cardiac functions. We aimed to determine whether these biomarkers are related to PP and placenta accreta.
METHODS: In this case-control study, fifty-four pregnant women who attended our tertiary care center for perinatology with the diagnosis of PP totalis, and of them, 14 patients with placenta accreta were recruited as the study groups. Forty-six uncomplicated control patients who were matched for age, BMI were also included. Maternal venous ProBNP, CK, CK-MB and Troponin I levels were compared between the three groups.
RESULTS: Obstetric history characteristics were comparable among groups, generally. CK and CK-MB levels were similar among three groups. Troponin I levels in the previa and accreta groups were significantly higher than the controls. ProBNP levels in the accreta group were significantly higher than other two groups. The multivariate regression model revealed that ProBNP could predict placental adhesion anomalies.
CONCLUSIONS: Troponin I and ProBNP levels in PP cases were higher than controls and ProBNP could predict placenta accreta.

Entities:  

Keywords:  Cardiac biomarkers; Troponin I; placenta accreta; placenta previa; pro-brain natriuretic peptide

Mesh:

Substances:

Year:  2016        PMID: 26864469     DOI: 10.3109/14767058.2016.1152576

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  4 in total

Review 1.  NT-proBNP: When is it useful in Obstetric Medicine?

Authors:  James A Ker; Priya Soma-Pillay
Journal:  Obstet Med       Date:  2017-11-22

Review 2.  Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers.

Authors:  Helena C Bartels; James D Postle; Paul Downey; Donal J Brennan
Journal:  Dis Markers       Date:  2018-07-03       Impact factor: 3.434

3.  Cardiac-specific troponins in uncomplicated pregnancy and pre-eclampsia: A systematic review.

Authors:  Samuel Dockree; Jennifer Brook; Brian Shine; Tim James; Lauren Green; Manu Vatish
Journal:  PLoS One       Date:  2021-02-26       Impact factor: 3.240

4.  Maternal Serum VEGF Predicts Abnormally Invasive Placenta Better than NT-proBNP: a Multicenter Case-Control Study.

Authors:  Alexander Schwickert; Frédéric Chantraine; Loreen Ehrlich; Wolfgang Henrich; Mustafa Zelal Muallem; Andreas Nonnenmacher; Philippe Petit; Katharina Weizsäcker; Thorsten Braun
Journal:  Reprod Sci       Date:  2020-10-06       Impact factor: 3.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.